ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
医药外包概念
2,798.200
-91.162
-3.16%
手动刷新
涨家数:
1
跌家数:
7
平家数:
- -
市盈率:
- -
高:
2,899.189
开:
2,888.717
低:
2,785.966
收:
2,889.362
成交量:
1.03亿
成交额:
34.49亿
市值:
6,388.25亿
流通市值:
2,705.92亿
数据加载中...
总览
新闻
药明生物交流纪要:上调增长预期,公司现金流充沛,没有融资需求
Buffett读书会
·
昨天
在创新药的大牛市里,资金还是最爱龙头
价值事务所
·
昨天
A股8月回购月报:央企巨头“组团”入场!药明康德上调回购价格上限后“速战速决”!
每日经济新闻
·
昨天
药明生物发布Green CRDMO白皮书,推动行业绿色转型
DoNews
·
昨天
港股异动 | 方达控股(01521)涨近10% 公司盈利能力迎来关键拐点 25Q2财务表现回升
智通财经
·
昨天
医药周周观 | 马君:创新药重磅BD连发,9月板块催化值得期待
银华理财家
·
昨天
港股异动 | 昭衍新药(06127.HK)跌超7% 董监高拟合计减持不超84.83万股公司A股股份
智通财经
·
昨天
美银:中国持续推进自主AI生态系统 助提升市场估值
AASTOCKS
·
昨天
药明康德盘中异动 早盘股价大跌3.07%
市场透视
·
昨天
药明生物(02269.HK)因期权获行使发行605.75万股
智通财经
·
昨天
昭衍新药公告董事、监事及高管减持计划;智翔金泰新药获得临床试验批准|医药早参
每日经济新闻
·
昨天
知名药企被罚800万元,澳洋健康或易主,长春高新1类新药申报临床,罗欣药业高管辞职,昭衍新药宣布减持
谈医说药
·
09/08
AMAC科研技术指数上涨2.12%,前十大权重包含伟测科技等
市场资讯
·
09/08
药明生物CEO陈智胜亲历中国创新药大爆发:以前跨国药企不太信任中国数据,但现在不同了
每日经济新闻
·
09/08
泰格医药:9月29日将召开2025年第一次临时股东会
证券日报网
·
09/08
小摩增持康龙化成(03759.HK)约133.82万股 每股作价约22.91港元
智通财经
·
09/08
首席运营官邵炜慧减持金斯瑞生物科技(01548)约11.55万股 每股作价约17.35港元
智通财经
·
09/08
2025中国生物医药行业全景调研与未来发展趋势分析
中研网
·
09/08
最高4180万元!一图了解A股总经理薪酬TOP10
东方财富研究中心
·
09/08
昭衍新药(06127):董监高拟合计减持不超过84.83万股公司A股股份
智通财经
·
09/08
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1576/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"医药外包概念","latestPrice":2798.2002,"timestamp":1757405290965,"preClose":2889.3618,"halted":0,"volume":103283715,"delay":0,"changeRate":-0.031551,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-91.161621,"latestTime":"09-09 16:00:00","open":2888.7168,"high":2899.1885,"low":2785.9658,"amount":3449259733,"amplitude":0.039186,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1757467800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1757381400000,1757390400000],[1757394000000,1757404800000]],"pbRate":3.481224,"peRate":15.25973,"turnoverRate":0.008789,"increases":1,"decrements":7,"flats":0,"marketCap":638825058304,"floatMarketCap":270591839232},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2899.1885,"amplitude":0.039186,"preClose":2889.3618,"low":2785.9658,"pbRate":"3.481224","latestPrice":2798.2002,"volume":103283715,"delay":0,"open":2888.7168,"prevYearClose":1395.7731,"prevWeekClose":2767.77,"prevMonthClose":2563.018,"prevQuarterClose":1988.255,"fiveDayClose":2735.462,"twentyDayClose":2352.903,"sixtyDayClose":2068.702,"secType":"PLATE","market":"HK","turnoverRate":0.008789,"peRate":15.25973,"marketCap":638825058304,"floatMarketCap":270591839232,"timestamp":1757405290965,"nameCN":"医药外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":1,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566618477","title":"药明生物交流纪要:上调增长预期,公司现金流充沛,没有融资需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2566618477","media":"Buffett读书会","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566618477?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 21:22","pubTimestamp":1757424179,"startTime":"0","endTime":"0","summary":"非药明合联的业务下半年比上半年还是有增长。如果按照药明生物的市场份额,将来全球每两个药中有一个药,药明生物就有销售提成。关于市场竞争Q:龙沙和三星在第二季度上调指引增加产能,公司有没有感觉到竞争加剧?A:公司现在有大概125亿人民币的现金。此外,公司还计划出售德国工厂以回收约10亿人民币的资金,从而进一步增强自由现金流。因此,从长远来看,公司现金流充足,没有融资需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909212601a719b60c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909212601a719b60c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516422952.EUR","LU0823426308.USD","LU0327786744.USD","LU0181495838.USD","LU1688375341.USD","LU0856984785.SGD","LU0417516902.SGD","BK1589","LU1242518931.SGD","LU0348825331.USD","BK1141","LU0359202008.SGD","LU1720050803.USD","LU0456846285.SGD","BK1521","LU2039709279.SGD","LU0320764599.SGD","LU1794554557.SGD","LU0052750758.USD","LU0140636845.USD","LU1242518857.USD","LU0051755006.USD","LU0326950275.SGD","BK1610","LU0516422366.SGD","LU0043850808.USD","LU0708995583.HKD","02269","LU0516422440.USD","IE00B0JY6N72.USD","SG9999002562.SGD","LU0359201612.USD","LU0516423091.SGD","LU0572944931.SGD","SG9999002463.SGD","LU0307460666.USD","LU0588546209.SGD","LU0819121731.USD","LU0979878070.USD","LU0456827905.SGD","LU0516423174.USD","LU0039217434.USD","LU0417516738.SGD","LU0348735423.USD","LU1880383366.USD","LU0823426480.USD","BK1576"],"gpt_icon":1},{"id":"2566618885","title":"在创新药的大牛市里,资金还是最爱龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2566618885","media":"价值事务所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566618885?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 20:58","pubTimestamp":1757422705,"startTime":"0","endTime":"0","summary":"届时,国内的创新药企,便不再只是国内的创新药企,而是世界的创新药企,他们的市值,也自然该向全球头部药企看齐。所以,如果我们想在资本市场掘金,那么这一波中国创新药全球崛起的浪潮,就一定不容错过,毕竟,在创新药这个充满变数的赛道上,今天的龙头未必是明天的赢家,一时的风口也可能转瞬即逝。毕竟,在创新药这个九死一生的领域里,活下去、持续在场,往往比孤注一掷赌对某一个标的更重要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909210106a719a86c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909210106a719a86c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02269","LU0327786744.USD","LU0588546209.SGD","SG9999002562.SGD","LU0417516738.SGD","LU2039709279.SGD","LU0052750758.USD","LU0039217434.USD","LU0140636845.USD","LU0051755006.USD","LU1688375341.USD","LU0516422440.USD","IE00B0JY6N72.USD","LU0572944931.SGD","LU0417516902.SGD","LU1242518857.USD","LU0516422952.EUR","LU0359202008.SGD","LU0823426480.USD","LU1242518931.SGD","BK1521","LU0819121731.USD","SG9999002463.SGD","LU0516423091.SGD","BK1576","LU0823426308.USD","LU1720050803.USD","BK1574","BK1610","LU0456846285.SGD","LU0516422366.SGD","LU0348735423.USD","LU1880383366.USD","LU0043850808.USD","LU0326950275.SGD","LU0348825331.USD","LU0456827905.SGD","BK1141","LU0359201612.USD","BK1161","LU0307460666.USD","06978","LU0320764599.SGD","LU0979878070.USD","LU0708995583.HKD","LU0181495838.USD","BK1589","LU0516423174.USD","LU1794554557.SGD","LU0856984785.SGD"],"gpt_icon":1},{"id":"2566692191","title":"A股8月回购月报:央企巨头“组团”入场!药明康德上调回购价格上限后“速战速决”!","url":"https://stock-news.laohu8.com/highlight/detail?id=2566692191","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566692191?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 19:44","pubTimestamp":1757418274,"startTime":"0","endTime":"0","summary":"药明康德上调回购价格上限后“速战速决”,另有多家公司已调整回购方案据同花顺数据统计,正在实施回购的公司中,约有420家公司发布了截至8月底的回购进展公告。其调整内容,主要包括以下几方面:一是调整回购价格上限。随后回购事项一直搁置,距离本次拟回购金额下限3000万元,仅完成了28.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090919450897831b1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090919450897831b1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","LU2543165471.USD","02359","BK1576","01276","BK1583","LU0359201885.HKD","LU0320764599.SGD","BK1141","03750","LU1023057109.AUD","LU0708995583.HKD","LU0359201612.USD","LU1046422090.SGD","BK1191","LU0052750758.USD","LU2045819591.USD","LU0359202008.SGD","LU2242644610.SGD"],"gpt_icon":1},{"id":"2566388691","title":"药明生物发布Green CRDMO白皮书,推动行业绿色转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2566388691","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566388691?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 19:07","pubTimestamp":1757416023,"startTime":"0","endTime":"0","summary":"药明生物在首届CRDMO+ Open Day活动中发布《Green CRDMO白皮书》,系统分享其端到端生物药绿色解决方案。该白皮书详细阐述了公司在可持续发展与气候变化方面的战略,聚焦研究、开发及生产环节的绿色创新技术,并汇总242项优秀节能案例,展现显著的节能减碳成果。这一举措将进一步推动全球生物药行业供应链向环保、高效方向发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909190916a7196941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909190916a7196941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0327786744.USD","BK1521","LU0572944931.SGD","LU1720050803.USD","LU1880383366.USD","LU0516423091.SGD","LU0516423174.USD","LU0052750758.USD","SG9999002562.SGD","LU0181495838.USD","LU0417516902.SGD","LU0823426308.USD","LU0039217434.USD","LU0823426480.USD","LU2039709279.SGD","LU0348735423.USD","02269","LU0456846285.SGD","LU0140636845.USD","LU0856984785.SGD","LU1242518857.USD","IE00B0JY6N72.USD","LU0043850808.USD","LU0819121731.USD","LU0326950275.SGD","BK1589","LU0348825331.USD","LU0588546209.SGD","LU1242518931.SGD","LU0307460666.USD","LU1688375341.USD","LU0516422952.EUR","LU0320764599.SGD","LU0417516738.SGD","SG9999002463.SGD","BK1141","LU1794554557.SGD","LU0359201612.USD","LU0979878070.USD","LU0456827905.SGD","LU0051755006.USD","LU0516422366.SGD","LU0708995583.HKD","BK1576","LU0516422440.USD","BK1610","LU0359202008.SGD"],"gpt_icon":0},{"id":"2566664819","title":"港股异动 | 方达控股(01521)涨近10% 公司盈利能力迎来关键拐点 25Q2财务表现回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2566664819","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566664819?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 15:20","pubTimestamp":1757402427,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,方达控股(01521)涨近10%,截至发稿,涨9.02%,报1.45港元,成交额192.5万港元。消息面上,方达控股发布截至2025年6月30日止6个月业绩,该集团期内取得收益1.27亿美元,同比减少1.5%;公司拥有人应占溢利292.7万美元,同比扭亏为盈;每股基本盈利0.0014美元。其中,集团于2025年第一季度录得亏损;得益于市场需求增加及生物制药公司为降低成本增加外包业务,集团第二季度财务表现有所回升,录得收益约6950万美元,同比增加7.8%,录得纯利约380万美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1343059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01521","BK1583","BK1576","BK1141"],"gpt_icon":0},{"id":"2566952906","title":"医药周周观 | 马君:创新药重磅BD连发,9月板块催化值得期待","url":"https://stock-news.laohu8.com/highlight/detail?id=2566952906","media":"银华理财家","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566952906?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 15:01","pubTimestamp":1757401295,"startTime":"0","endTime":"0","summary":"上周全指医药卫生指数大幅跑赢大盘,从行业子板块来看,创新药及产业链涨幅居前。半年报公布完毕,整体来看医药板块中报业绩情况平稳符合预期。处于向好阶段的创新药及产业链领域趋势可持续。除学术会议上临床数据外,上周也有两起BD事件,某非上市公司宣布与海外MNC达成一项新战略合作协议,双方共同开发多项心血管产品。进入9月,创新药板块有较多催化剂值得期待。仿创药企的仿制药业务稳定增长,创新药价值也将逐渐兑现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909150334a4bd809c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909150334a4bd809c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","09939","LU2125910500.SGD","LU2242644610.SGD","LU1046422090.SGD","BK1583","ZLAB","BK1515","LU0708995583.HKD","BK1576","BK1161","LU0052750758.USD","LU0320764599.SGD","LU2045819591.USD","02359","06978","BK1574","09995"],"gpt_icon":0},{"id":"2566666611","title":"港股异动 | 昭衍新药(06127.HK)跌超7% 董监高拟合计减持不超84.83万股公司A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2566666611","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566666611?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 14:10","pubTimestamp":1757398244,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","06127","BK0216","BK1141","399300","159982","603127"],"gpt_icon":0},{"id":"2566638366","title":"美银:中国持续推进自主AI生态系统 助提升市场估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2566638366","media":"AASTOCKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566638366?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 12:00","pubTimestamp":1757390433,"startTime":"0","endTime":"0","summary":"对于亚太地区在全球AI中的投资机会,美银中国研究部联席主管、首席中国策略师兼亚太区首席金融分析师吴旖称,尽管受到出口管制,中国仍在持续推进自主AI生态系统的建设。由于中国和韩国在AI应用上处于领先,她认为可能挑战对其股市的结构性悲观预期,提升估值倍数。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909124847a4bd2ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909124847a4bd2ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["M","80020","LU0359201612.USD","LU0823426480.USD","LU1688375341.USD","00981","SG9999002562.SGD","LU0320764599.SGD","BK1576","LU0043850808.USD","LU1794554557.SGD","LU1880383366.USD","LU0417516738.SGD","LU0823426308.USD","LU0516423174.USD","LU0516422366.SGD","LU0039217434.USD","LU0052750758.USD","LU0327786744.USD","LU0140636845.USD","BK1610","LU0708995583.HKD","LU0979878070.USD","LU0516422952.EUR","LU0417516902.SGD","LU0456846285.SGD","LU0516422440.USD","LU1720050803.USD","LU0348825331.USD","BK1589","BK1141","LU0456827905.SGD","LU0819121731.USD","LU0307460666.USD","02269","LU2039709279.SGD","LU0588546209.SGD","SG9999002463.SGD","LU0051755006.USD","LU0348735423.USD","TSM","NVDA","LU0856984785.SGD","LU0181495838.USD","00020","LU0359202008.SGD","LU1242518857.USD","02359","IE00B0JY6N72.USD","LU0572944931.SGD","BK1521","LU0326950275.SGD","LU0516423091.SGD","LU1242518931.SGD"],"gpt_icon":1},{"id":"2566957606","title":"药明康德盘中异动 早盘股价大跌3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566957606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566957606?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 10:20","pubTimestamp":1757384436,"startTime":"0","endTime":"0","summary":"2025年09月09日早盘10时20分,药明康德股票出现异动,股价急速跳水3.07%。截至发稿,该股报113.800港元/股,成交量199.983万股,换手率0.42%,振幅4.86%。药明康德股票所在的生物技术行业中,整体涨幅为1.41%。2024年,药明康德共实施了3次A股回购,合计金额30亿元。进入2025年,药明康德继续加大回购力度,相继完成了两轮总计金额达20亿元的股份回购,且每次回购后都将相应股份予以注销,进一步提升股东价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909102037a4bccc2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909102037a4bccc2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU2045819591.USD","LU2125910500.SGD","LU0708995583.HKD","02359","BK1583","LU2242644610.SGD","LU0052750758.USD","BK1576","LU0320764599.SGD","BK1141"],"gpt_icon":0},{"id":"2566658882","title":"药明生物(02269.HK)因期权获行使发行605.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2566658882","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566658882?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 06:23","pubTimestamp":1757370225,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0979878070.USD","BK1589","LU1688375341.USD","BK1141","LU0456827905.SGD","LU0456846285.SGD","LU0708995583.HKD","LU2039709279.SGD","LU0052750758.USD","LU0823426308.USD","LU0823426480.USD","LU0327786744.USD","LU1794554557.SGD","LU0588546209.SGD","LU0039217434.USD","LU0516422952.EUR","LU1720050803.USD","BK1521","LU0516423091.SGD","LU1880383366.USD","LU0359202008.SGD","LU1242518931.SGD","02269","LU0516422366.SGD","BK1610","LU1242518857.USD","LU0417516902.SGD","LU0516423174.USD","LU0320764599.SGD","LU0359201612.USD","LU0043850808.USD","SG9999002463.SGD","IE00B0JY6N72.USD","LU0348735423.USD","LU0516422440.USD","LU0572944931.SGD","LU0140636845.USD","LU0051755006.USD","LU0856984785.SGD","SG9999002562.SGD","LU0417516738.SGD","BK1576","LU0181495838.USD","LU0307460666.USD","LU0819121731.USD","LU0348825331.USD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2566658938","title":"昭衍新药公告董事、监事及高管减持计划;智翔金泰新药获得临床试验批准|医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2566658938","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566658938?lang=zh_cn&edition=fundamental","pubTime":"2025-09-09 06:18","pubTimestamp":1757369920,"startTime":"0","endTime":"0","summary":"NO.1汉邦科技收到《无效宣告请求审查决定书》汉邦科技于近日收到了国家知识产权局出具的《无效宣告请求审查决定书》。国家知识产权局对无效宣告请求人汉邦科技提出的思拓凡瑞典有限公司(英文名“Cytiva”)拥有的“分离介质浆料罐”(专利号:200980125060.3)专利权之无效宣告请求进行了审查,审查结论为宣告该专利权全部无效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509093507980026.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509093507980026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK1515","BK1161","BK1574","BK1576","09939","06127"],"gpt_icon":0},{"id":"2566946652","title":"知名药企被罚800万元,澳洋健康或易主,长春高新1类新药申报临床,罗欣药业高管辞职,昭衍新药宣布减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2566946652","media":"谈医说药","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566946652?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 23:17","pubTimestamp":1757344624,"startTime":"0","endTime":"0","summary":"公司于2024年3月26日获得申报受理通知书,并于近日获得国家药监局批准。此次解除质押的股份质押起始日为2023年9月11日,质押解除日为2025年9月5日,质权人为红塔证券股份有限公司。解除质押后,宁波雅本累计质押股份为8760万股,占其所持股份比例33.99%,占公司总股本比例9.09%。截至公告披露日,陈娴未持有公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908231958a716f9c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908231958a716f9c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","08058","BK1141"],"gpt_icon":0},{"id":"2565638566","title":"AMAC科研技术指数上涨2.12%,前十大权重包含伟测科技等","url":"https://stock-news.laohu8.com/highlight/detail?id=2565638566","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565638566?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 22:16","pubTimestamp":1757340962,"startTime":"0","endTime":"0","summary":"沪深京交易所数据显示,A股三大指数收盘涨跌不一,AMAC科研技术指数 上涨2.12%,报7456.45点,成交额306.03亿元。数据统计显示,AMAC科研技术指数近一个月上涨6.80%,近三个月上涨35.65%,年至今上涨48.38%。从AMAC科研技术指数持仓样本的行业来看,医药卫生占比68.45%、工业占比27.35%、信息技术占比2.03%、可选消费占比1.28%、原材料占比0.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908222811951cef64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908222811951cef64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","LU1046422090.SGD","LU0052750758.USD","LU2125910500.SGD","BK1141","BK1576","BK1583","03347","LU0708995583.HKD","06127","LU2045819591.USD","LU0320764599.SGD","LU2242644610.SGD","02359"],"gpt_icon":1},{"id":"2565136682","title":"药明生物CEO陈智胜亲历中国创新药大爆发:以前跨国药企不太信任中国数据,但现在不同了","url":"https://stock-news.laohu8.com/highlight/detail?id=2565136682","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565136682?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 21:32","pubTimestamp":1757338321,"startTime":"0","endTime":"0","summary":"2011年,陈智胜博士从美国回到中国。在9月4日的药明生物首届CRDMO+ 开放日活动上,陈智胜笑言,台下很多嘉宾是中国创新药最早的参与者,更是行业发展的推动者。十年时间,中国创新药已经跃升为全球第一梯队。2025年前5个月,中国生物创新药授权交易金额达到216亿美元,全球大型制药交易中来自中国创新药的占比达到38%。截至2025年6月底,药明生物帮助客户研发和生产的综合项目高达864个,其中包括24个商业化生产项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908213203951cd99b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908213203951cd99b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2039709279.SGD","LU0043850808.USD","LU0348735423.USD","BK1141","02359","06978","IE00B0JY6N72.USD","LU0456827905.SGD","LU0823426480.USD","LU0417516902.SGD","LU0456846285.SGD","LU0516422952.EUR","LU0856984785.SGD","BK1610","LU0708995583.HKD","BK1574","BK1576","LU0516423091.SGD","SG9999002562.SGD","LU0181495838.USD","LU0359201612.USD","LU0516422366.SGD","LU0823426308.USD","LU1242518931.SGD","LU0327786744.USD","LU0320764599.SGD","LU0039217434.USD","LU0140636845.USD","LU0307460666.USD","LU1688375341.USD","LU1880383366.USD","LU0051755006.USD","LU0516423174.USD","LU1794554557.SGD","SG9999002463.SGD","LU0516422440.USD","LU0052750758.USD","LU0588546209.SGD","LU0979878070.USD","LU0348825331.USD","LU1242518857.USD","LU1720050803.USD","BK1589","LU0819121731.USD","BK1161","LU0359202008.SGD","LU0326950275.SGD","02269","LU0417516738.SGD","BK1521","LU0572944931.SGD"],"gpt_icon":1},{"id":"2565689905","title":"泰格医药:9月29日将召开2025年第一次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2565689905","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565689905?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 19:41","pubTimestamp":1757331660,"startTime":"0","endTime":"0","summary":"证券日报网讯9月8日晚间,泰格医药发布公告称,公司将于2025年9月29日召开2025年第一次临时股东会。本次股东会将审议《关于修订<公司章程>的议案》等多项议案。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-08/doc-infpuwra9476619.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-08/doc-infpuwra9476619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1820825898.SGD","BK0077","BK0216","BK1583","BK0028","300347","BK1576","03347","BK1141","BK0174","LU1146622755.USD"],"gpt_icon":0},{"id":"2565683016","title":"小摩增持康龙化成(03759.HK)约133.82万股 每股作价约22.91港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565683016","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565683016?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 19:01","pubTimestamp":1757329311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443382.USD","SG9999002232.USD","LU0323591593.USD","LU0689472784.USD","LU2023250843.SGD","IE00B1BXHZ80.USD","BK1576","LU2592432038.USD","LU2430703251.USD","LU0496365809.HKD","LU1917777945.USD","LU1551013425.SGD","IE00BLSP4239.USD","LU1551013342.USD","LU0267386448.USD","LU2552382132.HKD","LU0320765489.SGD","LU1244550221.USD","LU1988902786.USD","LU2237443895.HKD","LU0006306889.USD","LU0943347566.SGD","LU0208291251.USD","LU1244550577.SGD","LU0320765646.SGD","LU1668664300.SGD","LU0234572021.USD","LU1894683264.USD","LU0820562030.AUD","LU2237443622.USD","IE0034235295.USD","LU2552382058.USD","IE00BLSP4452.SGD","LU1244550494.USD","03759","300759","LU0964807845.USD","LU0976567544.SGD","LU2430703178.SGD","LU2756315664.SGD","LU2552382215.SGD","LU0868494708.USD","LU0417517546.SGD","LU2456880835.USD","LU1267930490.SGD","LU0070302665.USD","LU0345770308.USD","LU0106831901.USD","LU0203345920.USD","LU1162221912.USD"],"gpt_icon":0},{"id":"2565683004","title":"首席运营官邵炜慧减持金斯瑞生物科技(01548)约11.55万股 每股作价约17.35港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565683004","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565683004?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 18:58","pubTimestamp":1757329125,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,9月3日,首席运营官邵炜慧减持金斯瑞生物科技(01548)11.5538万股,每股作价17.3544港元,总金额约为200.51万港元。减持后最新持股数目约为683.85万股,最新持股比例为0.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000306701.USD","HK0000306685.HKD","HK0000320223.HKD","01548","BK1583","BK1576","BK1141","HK0000320264.USD"],"gpt_icon":0},{"id":"2565050025","title":"2025中国生物医药行业全景调研与未来发展趋势分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2565050025","media":"中研网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565050025?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 18:11","pubTimestamp":1757326270,"startTime":"0","endTime":"0","summary":"中西部地区增速领先,成都天府生物城聚焦疫苗与血液制品,武汉光谷生物城主攻CAR-T疗法。根据中研普华产业研究院发布的《2025-2030年中国生物医药行业全景调研与发展趋势预测分析报告》显示:(三)产业链价值:上游突破与下游延伸上游供应链:国产替代加速,但在细胞培养基、色谱填料等高端领域仍依赖进口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509081811119780f4e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509081811119780f4e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0708995583.HKD","LU0052750758.USD","BK1583","LU2125910500.SGD","BK1576","LU0320764599.SGD","BK1141","06160","LU2242644610.SGD","LU2045819591.USD","02359","01276","LU1046422090.SGD","BK1574","06978"],"gpt_icon":1},{"id":"2565507779","title":"最高4180万元!一图了解A股总经理薪酬TOP10","url":"https://stock-news.laohu8.com/highlight/detail?id=2565507779","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565507779?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 17:54","pubTimestamp":1757325282,"startTime":"0","endTime":"0","summary":"若特斯拉股价按规划上涨,且公司达成特定里程碑,这一薪酬将接近1万亿美元,即平均每年1000亿美元,是2024年A股上市公司总经理年薪总和的近100倍。据东方财富Choice数据显示,2024年全部A股总经理薪酬达74.36亿元,平均薪酬为141万元,薪酬超千万的有21人。其中薪酬最高的是药明康德董事长兼总经理李革,达4180万元,薪酬最低的是亚联发展的董事长兼总经理王永彬,为0.66万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908175910951c8a69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908175910951c8a69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU2125910500.SGD","LU2242644610.SGD","BK1583","LU0708995583.HKD","BK1576","LU0052750758.USD","LU0320764599.SGD","02359","LU2045819591.USD","LU1046422090.SGD"],"gpt_icon":0},{"id":"2565502846","title":"昭衍新药(06127):董监高拟合计减持不超过84.83万股公司A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2565502846","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565502846?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 17:07","pubTimestamp":1757322448,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昭衍新药 发布公告,孙云霞、高大鹏、顾静良拟自本减持计划公告之日起15个交易日后即2025年9月30日至2025年11月28日,通过上海证券交易所大宗交易或集中竞价的方式分别减持不超过67.47万股、7.21万股、6.74万股;李叶、于爱水拟自本减持计划公告之日起15个交易日后即2025年9月30日至2025年11月28日,通过上海证券交易所集中竞价的方式分别减持不超过2.56万股、8500股,前述减持合计不超过84.83万股,不超过公司当前总股本的0.1132%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","603127","159982","06127","399300","BK1576","BK1141"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":168,"code":"91000000","status":"200"}]}}